Literature DB >> 16801588

Use of HbA1c in predicting progression to diabetes in French men and women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR).

Celine Droumaguet1, Beverley Balkau, Dominique Simon, Emile Caces, Jean Tichet, Marie Aline Charles, Eveline Eschwege.   

Abstract

OBJECTIVE: Early identification of subjects at high risk for diabetes is essential, and random HbA(1c) (A1C) may be more practical than fasting plasma glucose (FPG). The predictive value of A1C, in comparison to FPG, is evaluated for 6-year incident diabetes. RESEARCH DESIGN AND METHODS: From the French cohort study Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR), 1,383 men and 1,437 women, aged 30-65 years, were volunteers for a routine health check-up. Incident diabetes was defined by FPG >or=7.0 mmol/l or treatment by antidiabetic drugs. Multivariate logistic regression models were used to predict diabetes at 6 years. Receiver operating characteristic curves compared the predictive values of A1C and FPG.
RESULTS: At 6 years, 30 women (2.1%) and 60 men (4.3%) had developed diabetes. Diabetes risk increased exponentially with A1C in both sexes (P < 0.001). After stratifying on FPG, A1C predicted diabetes only in subjects with impaired fasting glucose (IFG) (FPG >or=6.10 mmol/l): the odds ratio (95% CI) for a 1% increase in A1C was 7.20 (3.00-17.00). In these subjects, an A1C of 5.9% gave an optimal sensitivity of 64% and specificity of 77% to predict diabetes.
CONCLUSIONS: A1C predicted diabetes, even though the diagnosis of diabetes was based on FPG, but it was less sensitive and specific than FPG. It could be used as a test if fasting blood sampling was not available or in association with FPG. In subjects with IFG, A1C is better than glucose to evaluate diabetes risk, and it could be used to select subjects for intensive early intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801588     DOI: 10.2337/dc05-2525

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  57 in total

1.  Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspective.

Authors:  Chris Degeling; Melanie Rock
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

2.  Use of HbA(1c) in screening for Cuban-Americans with undiagnosed type 2 diabetes.

Authors:  Fatma G Huffman; Joel C Exebio; Gustavo G Zarini; Cristobal Exebio
Journal:  J Immigr Minor Health       Date:  2011-06

3.  The changing relationship between HbA1c and FPG according to different FPG ranges.

Authors:  X Guan; L Zheng; G Sun; X Guo; Y Li; H Song; F Tian; Y Sun
Journal:  J Endocrinol Invest       Date:  2015-09-18       Impact factor: 4.256

4.  International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 17.152

5.  A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  Carlos Lorenzo; Lynne E Wagenknecht; Anthony J G Hanley; Marian J Rewers; Andrew J Karter; Steven M Haffner
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 19.112

6.  Postchallenge glucose, A1C, and fasting glucose as predictors of type 2 diabetes and cardiovascular disease: a 10-year prospective cohort study.

Authors:  Henna Cederberg; Tuula Saukkonen; Mauri Laakso; Jari Jokelainen; Pirjo Härkönen; Markku Timonen; Sirkka Keinänen-Kiukaanniemi; Ulla Rajala
Journal:  Diabetes Care       Date:  2010-06-23       Impact factor: 17.152

Review 7.  A1C level and future risk of diabetes: a systematic review.

Authors:  Xuanping Zhang; Edward W Gregg; David F Williamson; Lawrence E Barker; William Thomas; Kai McKeever Bullard; Giuseppina Imperatore; Desmond E Williams; Ann L Albright
Journal:  Diabetes Care       Date:  2010-07       Impact factor: 19.112

8.  Are There Clinical Implications of Racial Differences in HbA1c? A Difference, to Be a Difference, Must Make a Difference.

Authors:  Elizabeth Selvin
Journal:  Diabetes Care       Date:  2016-08       Impact factor: 19.112

9.  A1C predicts type 2 diabetes and impaired glucose tolerance in a population at risk: the community diabetes prevention project.

Authors:  Silmara Ao Leite; Robyn L Anderson; David M Kendall; Arlene M Monk; Richard M Bergenstal
Journal:  Diabetol Metab Syndr       Date:  2009-09-16       Impact factor: 3.320

10.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2010-01       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.